| To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers (NCT01457807) | AstraZeneca | 2011-11-01 |
| Safety, Tolerability and Pharmacodynamic Activity of JNJ-26528398 in Healthy Male Participants (NCT01520142) | Janssen Research & Development, LLC | 2011-11-01 |
| Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer (NCT01384799) | Curis, Inc. | 2011-11-01 |
| A Drug-Drug Interaction Study of Warfarin and PA21 (NCT01477424) | Vifor Pharma | 2011-11-01 |
| Open Label Phase 1 Pharmacokinetics and Tolerability Study of Single TAB08 Administration in Healthy Volunteers (NCT01885624) | Theramab LLC | 2011-11-01 |
| Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 (NCT01816815) | Bayer | 2011-11-01 |
| Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers (NCT01461174) | Qualissima | 2011-11-01 |
| A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease (NCT01482845) | Abbott | 2011-11-01 |
| Clinical Evaluation of the Zynex Blood Volume Monitor (CM-1500) in Healthy Male Adult Subjects During a Blood Draw (NCT01646060) | Zynex Monitoring Solutions | 2011-11-01 |
| A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) (NCT01482715) | pharmaand GmbH | 2011-11-01 |
| A Phase 1 Study To Evaluate The Pharmacokinetics And Safety Of Three Modified Release And One Immediate Release Formulations Of Tofacitinib (CP-690,550) In Healthy Volunteers (NCT01499004) | Pfizer | 2011-11-01 |
| Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant (NCT01164514) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-11-01 |
| A Trial Investigating the Pharmacokinetic Properties of Formulations of NN1218 in Subjects With Type 1 Diabetes (NCT01469143) | Novo Nordisk A/S | 2011-11-01 |
| A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function (NCT01419041) | Pfizer | 2011-11-01 |
| Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214 (NCT01458899) | AstraZeneca | 2011-11-01 |
| Safety and Immunogenicity of a Human Hookworm Candidate Vaccine With or Without Additional Adjuvant in Brazilian Adults (NCT01261130) | Baylor College of Medicine | 2011-11-01 |
| A Open-label Food Effect Study With SEN0014196 in Subjects With Huntington Disease (NCT01485965) | Siena Biotech S.p.A. | 2011-11-01 |
| Intravitreal Ranibizumab 0.5MG, or 1.0mg for RVO With Macular Edema Previously Receiving Bevacizumab (NCT01471691) | Hanscom, Thomas, M.D. | 2011-11-01 |
| Administration of Donor T Cells With the Caspase-9 Suicide Gene (NCT01494103) | Baylor College of Medicine | 2011-11-01 |
| Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes (NCT01479998) | Yale University | 2011-11-01 |
| Inhaled Vancomycin Tolerability, Safety and Pharmacokinetics (NCT01537666) | Savara Inc. | 2011-11-01 |
| Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans (NCT01900340) | University Hospital, Basel, Switzerland | 2011-11-01 |
| Spinal Cord Injury Leg Rehabilitation (NCT01498991) | Oregon Health and Science University | 2011-11-01 |
| Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer (NCT01485874) | Hoosier Cancer Research Network | 2011-11-01 |
| Evaluating Three Grams Daily Valacyclovir in Patients With Chronic Hepatitis C and HSV-2 Infection (Phase I) (NCT01453075) | VA Office of Research and Development | 2011-11-01 |
| A Phase Ib Study to Assess Safety and Efficacy of Oral Icaritin in Advanced Solid Tumors (NCT02496949) | Chinese Academy of Medical Sciences | 2011-11-01 |
| Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects (NCT01467726) | Alfasigma S.p.A. | 2011-11-01 |
| Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke (NCT01468064) | Southern Medical University, China | 2011-11-01 |
| Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation (NCT01460420) | European Myeloma Network B.V. | 2011-11-01 |
| Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis (NCT01440309) | Robert Chunhua Zhao, MD, PhD | 2011-11-01 |
| A Phase 1, Open-Label, Single-Dose, Pharmacokinetic and Safety Study of E7080 (24 mg) Administered to Subjects With Mild, Moderate, and Severe Renal Impairment and to Healthy Subjects (NCT02199379) | Eisai Inc. | 2011-11-01 |
| Comparative Bioequivalence Study of Wockhardt's Insulin Analogue Mixture Listro Mix 75/25® and Humalog Mix75/25 ® in Healthy Subjects (NCT01400802) | Wockhardt | 2011-11-01 |
| Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-462206 (NCT01954589) | Idorsia Pharmaceuticals Ltd. | 2011-11-01 |
| IIT CTI Bendamustine, Rituximab, Pixantrone in Relapsed/Refractory B Cell Non-Hodgkin's Lymphoma (NCT01491841) | Anne Beaven, MD | 2011-11-01 |
| Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring (NCT01363037) | International Partnership for Microbicides, Inc. | 2011-11-01 |
| Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma (NCT01402440) | Novartis Pharmaceuticals | 2011-11-01 |
| Symphony: The Implantable Counter Pulsation Device (CPD) Safety and Feasibility Trial (NCT01543022) | Abiomed Inc. | 2011-11-01 |
| Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus (NCT01493115) | Sanofi | 2011-11-01 |
| Drug Interaction Study of Isavuconazole and Cyclosporine (NCT01494597) | Astellas Pharma Inc | 2011-11-01 |
| A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects (NCT01467531) | ViiV Healthcare | 2011-11-01 |
| Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants (NCT01497431) | National Cancer Institute (NCI) | 2011-11-01 |
| Safety Study of Group A, C, Y & W-135 Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine for Meningitis (NCT01482052) | JN-International Medical Corporation | 2011-11-01 |
| Age-dependent Effects of Flavanols on Vascular Status (NCT01639781) | Heinrich-Heine University, Duesseldorf | 2011-11-01 |
| Phase 1 Multiple Ascending Dose Study of BMS-833923 (XL139) in Subjects With Solid Tumors (NCT01413906) | Bristol-Myers Squibb | 2011-11-01 |
| Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function (NCT01443481) | Novartis Pharmaceuticals | 2011-11-01 |
| Phase 1b/2 Study of U3-1287 in Combination With Trastuzumab Plus Paclitaxel in Newly Diagnosed Metastatic Breast Cancer (MBC) (NCT01512199) | Daiichi Sankyo | 2011-11-01 |
| Adiponectin Polymorphisms, Insulin Resistance, and Pharmacokinetics in Obesity (NCT01593397) | Stanford University | 2011-11-01 |
| A Pilot Study Using Placenta Derived Decidual Stromal Cells for Hemorrhagic Cystitis (NCT02172963) | Karolinska Institutet | 2011-11-01 |
| Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder (NCT01369459) | The National Center on Addiction and Substance Abuse at Columbia University | 2011-11-01 |
| Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies (NCT01168882) | Agennix | 2011-11-01 |
| Paracetamol and Pharmacogenetic (NCT01520792) | University Hospital, Clermont-Ferrand | 2011-11-01 |
| Genotype-driven Phase I Study of Irinotecan Administered in Neoadjuvant Chemoradiotherapy in Patients With Stage II/III Rectal Cancer (NCT01474187) | Fudan University | 2011-11-01 |
| A Therapeutic Equivalence Study of Two Oxiconazole Nitrate Topical Cream Treatments for Patients With Tinea Pedis (NCT01519752) | Sun Pharmaceutical Industries, Inc. | 2011-11-01 |
| A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma (NCT01464034) | Criterium, Inc. | 2011-11-01 |
| ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers (NCT01483911) | Ablynx, a Sanofi company | 2011-11-01 |
| Tailored Intervention to Promote Positive Airway Pressure Adherence (NCT01454830) | Milton S. Hershey Medical Center | 2011-11-01 |
| Acupuncture Treatment for Gastroparesis: a Pilot Study (NCT01643577) | Johns Hopkins University | 2011-11-01 |
| A Phase I Study of Oral MEK162 in Japanese Patients With Advanced Solid Tumors (NCT01469130) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2011-11-01 |
| Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet (NCT01443208) | Pfizer | 2011-11-01 |
| Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL). (NCT01389427) | The Lymphoma Academic Research Organisation | 2011-11-01 |
| The Biomechanical Effects of Flaccid Paralysis Induced by Botulinum Toxin a After Damage Control Laparotomy (NCT01495962) | Mayo Clinic | 2011-11-01 |
| A Clinical Pharmacology of KHK4827 in Healthy Volunteers and Subject With Moderate to Severe Psoriasis (NCT01488201) | Kyowa Kirin Co., Ltd. | 2011-11-01 |
| Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505 (NCT01474161) | Genfit | 2011-11-01 |
| A Drug Interaction Study of Montelukast and Levocetirizine (NCT01491503) | Hanmi Pharmaceutical Company Limited | 2011-11-01 |
| Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension (NCT01479010) | Virginia Commonwealth University | 2011-11-01 |
| A 6 Week Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of GK1-399 in Type 2 Diabetes (NCT01474083) | vTv Therapeutics | 2011-11-01 |
| Phase I/II for Safety and Efficacy of Nilotinib in a Population Steroid-refractory/or Steroid-dependent cGVHD (NCT01810718) | Gruppo Italiano Trapianto di Midollo Osseo | 2011-11-01 |
| Split-face Comparison Study to Assess ELAPR Compared to Juvéderm® for the Treatment of Nasolabial Folds (NCT01463657) | Elastagen Pty Ltd | 2011-11-01 |
| A Bioequivalence Study Comparing HIP0901 Capsule With Lipidilsupra Tablet (NCT01509196) | Hanmi Pharmaceutical Company Limited | 2011-11-01 |
| Study to Determine Results of Vibratory Stimulus on Subject's Neck (NCT01491828) | Kai Medical, Inc. | 2011-11-01 |
| Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I) (NCT01476332) | Laurantis Pharma, Ltd. | 2011-11-01 |
| Effects of Proteins Fraction Derived From Milk on Osteoporosis Prevention (NCT01478724) | Soredab | 2011-11-01 |
| Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part I (NCT01463488) | Sanofi | 2011-11-01 |
| Safety and Dialysability of Dotarem® in Dialysed Patients (NCT01449266) | Guerbet | 2011-11-01 |
| rTMS and Retraining in Focal Hand Dystonia (NCT01738581) | University of Minnesota | 2011-11-01 |
| Lentiviral Gene Therapy for X-Linked Chronic Granulomatous Disease (X-CGD) (NCT01381003) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2011-11-01 |
| Comparative Study of the Magnetic-controlled Capsule Endoscopy Versus Standard Gastroscopy (NCT01903629) | Changhai Hospital | 2011-11-01 |
| A Study To Estimate The Effect Of Repeated Dosing of PF-05175157 On The Pharmacokinetics Of A Single Dose Of Simvastatin In Healthy Adult Subjects (NCT01469468) | Pfizer | 2011-11-01 |
| Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease (NCT01434693) | Coronado Biosciences, Inc. | 2011-11-01 |
| Dorsal Penile Block for Post-Robotic Prostatectomy Foley Discomfort (NCT01565512) | Columbia University | 2011-11-01 |
| A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz (NCT01472380) | Mutual Pharmaceutical Company, Inc. | 2011-11-01 |
| Chlorambucil + Lenalidomide and Lenalidomide Maintenance in Untreated Elderly With Chronic Lymphocytic Leukemia (CLL) (NCT01403246) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2011-11-01 |
| Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949 (NCT02099071) | Idorsia Pharmaceuticals Ltd. | 2011-11-01 |
| Study of PM01183 in Non-Colorectal Cancer Patients as a Days 1 and 8 Intravenous Short Infusion Every 3 Weeks (NCT01405391) | PharmaMar | 2011-11-01 |
| ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia (NCT01478074) | Altor BioScience | 2011-11-01 |
| Sauna Detoxification Study: Pilot Feasibility (NCT01576822) | Bastyr University | 2011-11-01 |
| Deuteporfin Tolerance and Pharmacokinetics in Healthy Volunteers (NCT01481597) | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2011-11-01 |
| A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus (NCT01470313) | Pfizer | 2011-11-01 |
| Combination Therapy of Gemcitabine and Trabectedin in L-sarcomas (NCT01426633) | Heidelberg University | 2011-11-01 |
| The Effect of Multiple Doses of Epanova® on the Multiple-Dose Pharmacokinetics of Simvastatin in Healthy Normal Subjects (NCT01486433) | AstraZeneca | 2011-11-01 |
| A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects (NCT01809860) | Astellas Pharma Global Development, Inc. | 2011-11-01 |
| Bioavailability Study of MLDL1278A After Subcutaneous and Intravenous Administration in Healthy Subjects (NCT01486823) | BioInvent International AB | 2011-11-01 |
| Zostavax in Systemic Lupus Erythematosus (NCT01474720) | Oklahoma Medical Research Foundation | 2011-11-01 |
| Distribution of Rubidium-82, Nitrogen-13 Ammonia, and Fluorine-18 Fluorodeoxyglucose in Normal Volunteers (NCT01433705) | University of Michigan | 2011-11-01 |
| A First-in-Human Study of LY3009385 in Healthy Participants (NCT01477567) | Eli Lilly and Company | 2011-11-01 |
| A Study to Compare the Pharmacokinetics and Pharmacodynamics of LY2963016 to Lantus in Healthy Participants (NCT01476345) | Eli Lilly and Company | 2011-11-01 |
| A Single Dose Study Of PF-06291874 In Healthy Adult Subjects (NCT01499017) | Pfizer | 2011-11-01 |
| Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion (NCT02749032) | Michael A. Nauck | 2011-11-01 |
| Study of a Probiotic Strain to Prevent Mastitis and to Eradicate GBS Colonization (NCT01505361) | Universidad Complutense de Madrid | 2011-11-01 |
| Behavioral Treatments for Anxiety and Depression in Veterans With Parkinson's Disease (NCT01323699) | Michael E. DeBakey VA Medical Center | 2011-11-01 |